Intake of Camelina Sativa Oil and Fatty Fish Alter the Plasma Lipid Mediator Profile in Subjects with Impaired Glucose Metabolism – A Randomized Controlled Trial
Several clinical trials have studied the effects of n-3 polyunsaturated fatty acids (PUFA) on lipid mediators [1-4]. However, these trials have mainly been conducted with either eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) as fish oil supplements or with flaxseeds or flaxseed oil, which is a rich source of α-linolenic acid (ALA). There are no previous studies comparing the effects of n-3 PUFAs from different dietary sources in parallel, such as fatty fish and Camelina sativa -oil (CSO), on lipid mediators.
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - Category: Biomedical Science Authors: Topi Meuronen, Maria A. Lankinen, Alexander Fauland, Bun-ichi Shimizu, Vanessa D. de Mello, David E. Laaksonen, Craig E. Wheelock, Arja T. Erkkil ä, Ursula S. Schwab Tags: Research article Source Type: research
More News: Biomedical Science | Clinical Trials | Diets | Fish | Fish Oil | Flaxseed | Nutrition | Study